Clara Biotech announced as Finalist in MedTech Innovators, BioTools Innovator Accelerator!
Clara Biotech is proud to announce it has been selected as a Finalist company in the BioTools Innovator 2021 Finals Competition. The selection committee included venture capitalists and industry experts. Queue the 🎉
The 3-month accelerator program culminates in the Finalist Competition, where the winner of the competition will walk away with a $200,000 grand prize powered by MedTech Innovator.
“We’re so proud of our team and ecstatic to be recognized as one of the most innovative biotech companies of 2021. With everyone’s help, we’ve managed to highlight the importance of exosomes in the next generation of medicine, and we want to send out a special thank you to everyone who has supported us along the way,” says Jim West, CEO Clara Biotech.
Clara Biotech would be grateful if you could continue sharing and liking their 1-minute video in the mini commercial competition, which ends on October 12, 2021, where we can win additional prizes.
Clara would like to congratulate the other finalist companies:
Follow us on Twitter to get the live updates on the day!
About Clara Biotech Clara Biotech enables tomorrow’s medical breakthroughs today through exosomes. The company solves the major roadblock preventing exosome solutions from reaching patients — purification of exosomes from biofluids. Clara Biotech’s solution enables breakthroughs in diagnostics and therapeutic pathways for a wide variety of conditions, including cancer, Alzheimer’s Disease, multiple sclerosis, ischemic stroke, and more. For more information, visit clarabio.tech.